Michael Wechsler
National Jewish Health, 1400 Jackson St Denver, CO 80206 · National Jewish Health · Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Wechsler as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:54 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04157348 · Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.AstraZeneca · active not recruiting · Eosinophilic Granulomatous Vasculitis · principal investigator
- Ph2NCT03010436 · Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyNational Jewish Health · active not recruiting · Asthma · principal investigator
- Ph2NCT02947945 · Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyNational Jewish Health · recruiting · Asthma · principal investigator
- N/ANCT01143688 · Characterization of Placebo Responses in Stable AsthmaBrigham and Women's Hospital · completed · Asthma Placebo Effects · principal investigator
- Ph1/Ph2NCT00527566 · Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss SyndromeBrigham and Women's Hospital · completed · Churg Strauss Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 1/2 Precision Tapering of Biologic Therapy in Asthma: Identifying Predictors of Successful Dupilumab Interval ExtensionUG3HL188699 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2026 · $2,099,722 awarded in 2026Same name and institution; not confirmed by an ID
- Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)UG1HL139123 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2017 to 2022 · $350,274 awarded in 2022Same name and institution; not confirmed by an ID
- Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trialU01AI097073 · NIAID · NATIONAL JEWISH HEALTH · fiscal years 2013 to 2016 · $1,251,988 awarded in 2016Same name and institution; not confirmed by an ID
- 58th Annual Aspen Lung ConferenceR13HL127976 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2015 · $20,000 awarded in 2015Same name and institution; not confirmed by an ID
- Clinical Centers for the NHLBI Asthma Network (AsthmaNet)U10HL098075 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2014 to 2015 · $336,493 awarded in 2015Same name and institution; not confirmed by an ID
- The Reliability of the Placebo Effect in AsthmaR21AT002793 · NCCIH · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2006 to 2007 · $338,614 awarded in 2007Grant number is on one of their registry trials
- Polymorphisms of Neural NOS and the Asthma PhenotypeK23HL004285 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2001 to 2005 · $133,920 awarded in 2005Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Mentoring and Research in Placebo Studies, Asian Medicine, and CAMK24AT004095 · NCCIH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Ted Kaptchuk · fiscal years 2007 to 2016Named on NCT01143688
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:54 UTC. The ranking covers the 200 most relevant of 82 PubMed records, and a shared surname and initials can bring in a namesake. All 82 on PubMed
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.Lancet Respir Med · 2015900 citationsRCR 33.1
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.N Engl J Med · 2021885 citationsRCR 61.1
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.N Engl J Med · 2017815 citationsRCR 37.5
- Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.Am J Respir Crit Care Med · 2010539 citationsRCR 16.7
- 462 citationsRCR 11.8
- Tiotropium bromide step-up therapy for adults with uncontrolled asthma.N Engl J Med · 2010412 citationsRCR 12.8
- 374 citationsRCR 24.3
- Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.Am J Respir Crit Care Med · 2007347 citationsRCR 9.7
- 297 citationsRCR 20.9
- Daily versus as-needed corticosteroids for mild persistent asthma.N Engl J Med · 2005283 citationsRCR 8.1